This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Abbott Laboratories Corporation. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Lutz Deitinghoff: Innovator in Drug Screening and Nervous System Disorders
Introduction
Lutz Deitinghoff is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of drug screening, particularly in relation to the interaction between repulsive guidance molecules and Neogenin. His work has implications for treating various disorders of the nervous system, angiogenic disorders, and malignancies.
Latest Patents
Lutz Deitinghoff holds 1 patent for his invention titled "Modulators and modulation of the interaction between RGM and Neogenin." This invention focuses on drug screening using mammalian repulsive guidance molecules and mammalian Neogenin. It also provides methods for preventing, alleviating, or treating various disorders by disrupting the interaction between RGM and Neogenin.
Career Highlights
Throughout his career, Lutz has worked with prominent organizations such as Abbott Laboratories Corporation and Yale University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Lutz has collaborated with notable individuals, including Stephen M. Strittmatter and Bernhard K. Mueller. These collaborations have further enhanced his research and innovation in the field of drug screening and treatment methodologies.
Conclusion
Lutz Deitinghoff's innovative work in drug screening and his contributions to understanding nervous system disorders highlight his importance as an inventor. His patent and collaborations reflect his commitment to advancing medical science and improving treatment options for various health conditions.